Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...

Shao Zhimin (right), director of general surgery and breast surgery departments of the Fudan University Shanghai Cancer Center and leader of the clinical study, is working on a patient case.

Shanghai Institute of Organic Chemistry has described leucine-rich repeat kinase 2 (LRRK2; dardarin) inhibitors reported to be useful for the treatment of cancer, autoimmune diseases, inflammatory ...

At Shanghai SinoUnited Hospital, he achieved complete remission, meaning he was cancer free, after just one month and a checkup three months later confirmed he was cancer free on a PET-CT ...